If this is not your name, click here.
| | If this is not your name, click here. | | |
| | Contact Us | Order Now | Journals | Bookstore | Register a colleague | | |
| |  Combined Mammography, Breast MRI Useful for Some High-Risk Women OAK BROOK, Ill -- February 23, 2010 -- Annual breast cancer screening with both mammography and magnetic resonance imaging (MRI) is likely to be a cost-effective way to improve life expectancy in women with an increased risk of breast cancer, according to a study published in the March issue of Radiology. The findings support current American Cancer Society screening recommendations. “For women at the highest risk of breast cancer, using both breast MRI and mammography together for screening will likely reduce their chances of dying from breast cancer and help them live longer, healthier lives,” said lead author Janie M. Lee, MD, Massachusetts General Hospital, Boston, Massachusetts. Women with certain mutations in the BRCA1 gene have a significantly increased lifetime risk of developing breast cancer. Mammography, the current standard for breast cancer screening in the general population, detects fewer than half of breast cancers in these high-risk women, in part because their younger age at screening and associated increased breast density make visualising tumours challenging. While breast MRI is a useful adjunct to mammography for screening women at increased genetic risk of breast cancer, it is more time consuming and expensive than mammography and has a higher incidence of false-positive findings. For the study, Dr. Lee and colleagues compared the costs and benefits of film mammography, of MRI, and of combined mammography and MRI in a hypothetical group of 25-year-old women with BRCA1 mutations. The researchers used statistical modeling to estimate the number of quality adjusted life years (QALYs) gained by screening, along with lifetime costs. Annual combined screening was best at detecting early stage cancers and provided the greatest relative mortality reduction. Combined screening became more cost-effective as breast cancer risk increased, and less cost-effective as risk decreased. MRI screening was associated with an increase in false-positive results. Annual mammography resulted in 37 false-positive screening examinations for every breast cancer death averted. The addition of annual MRI increased the number of false-positive results to 137 for each breast cancer death averted. “The benefits provided by MRI are balanced by an increased chance of needing additional tests to evaluate a possible abnormality, and perhaps even a biopsy that might in the end show no cancer,”“ Dr. Lee said.
SOURCE: Radiological Society of North America
|
